Pharmacoeconomics of aztreonam-clindamycin versus gentamicin-clindamycin in the treatment of penetrating abdominal injury

Pharmacotherapy

Volumn 16, Issue 5 I, 1996, Pages 951-957

  Fabian, Timothy C ^a   Boucher, Bradley A ^a,b   Croce, Martin C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Clinical Pharmacy ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CLINDAMYCIN; GENTAMICIN;

ABDOMINAL PENETRATING TRAUMA; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; WOUND INFECTION;

ABDOMINAL INJURIES; ADULT; AZTREONAM; CLINDAMYCIN; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HEALTH CARE COSTS; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITALS, TEACHING; HUMANS; MALE; RETROSPECTIVE STUDIES; TENNESSEE;

EID: 0029763564     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. DiPiro JT, Fortson NS. Combination antibiotic therapy in the management of intraabdominal infection. Am J Surg 1993;165(2A suppl):82S-8.
2. Hooker KD, DiPiro JT, Wynn JJ. Aminoglycoside combinations versus beta-lactams alone for penetrating abdominal trauma: a meta analysis. J Trauma 1991;31:1155-60.
3. Fabian TC, Hess MM, Croce MA, et al. Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. Am J Surg 1994;167:291-6.
4. Moore EE, Dunn EL, Moore JB, et al. Penetrating abdominal trauma index. J Trauma 1981;21:439-44.
5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
6. Sifton D, ed. Red book. Montvale, NJ: Medical Economics Data, 1992.
7. Judge GC, ed. Introduction to the theory and practice of econometrics. New York: John Wiley & Sons, 1985:416-17.
8. Okamoto MP, Gill MA, Nakahiro RK, et al. Cost analysis of cefmetazole versus cefoxitin in the treatment of penetrating abdominal trauma. Curr Ther Res 1993;53:159-66.
9. Friedrich LV, While RL, Kays MB, et al. Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma. Am J Hosp Pharm 1992;49:590-4.
10. de Lissovoy G, Elixhauser A, Luce BR, et al. Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intraabdominal infection. PharmacoEconomics 1993;4:203-14.
11. Solomkin JS, Dellinger EP, Christou NY, Busuttil RW. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg 1990;212:581-91.
12. Kreter B. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin + aminoglycoside combination therapy For treatment of serious lower respiratory, intraabdominal, gynecologic, and urinary tract infections. Clin Ther 1992;14:110-21.